121 related articles for article (PubMed ID: 8593483)
1. Hinokitiol induces differentiation of teratocarcinoma F9 cells.
Muto N; Dota A; Tanaka T; Itoh N; Okabe M; Inada A; Nakanishi T; Tanaka K
Biol Pharm Bull; 1995 Nov; 18(11):1576-9. PubMed ID: 8593483
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by hinokitiol, a potent iron chelator, in teratocarcinoma F9 cells is mediated through the activation of caspase-3.
Ido Y; Muto N; Inada A; Kohroki J; Mano M; Odani T; Itoh N; Yamamoto K; Tanaka K
Cell Prolif; 1999 Feb; 32(1):63-73. PubMed ID: 10371304
[TBL] [Abstract][Full Text] [Related]
3. Induction of differentiation of embryonal carcinoma F9 cells by iron chelators.
Tanaka T; Muto N; Itoh N; Dota A; Nishina Y; Inada A; Tanaka K
Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):211-20. PubMed ID: 8747790
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis during iron chelator-induced differentiation in F9 embryonal carcinoma cells.
Tanaka T; Satoh T; Onozawa Y; Kohroki J; Itoh N; Ishidate M; Muto N; Tanaka K
Cell Biol Int; 1999; 23(8):541-50. PubMed ID: 10704238
[TBL] [Abstract][Full Text] [Related]
5. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL
Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346
[TBL] [Abstract][Full Text] [Related]
6. Reversible effects of sodium butyrate on the differentiation of F9 embryonal carcinoma cells.
Kosaka M; Nishina Y; Takeda M; Matsumoto K; Nishimune Y
Exp Cell Res; 1991 Jan; 192(1):46-51. PubMed ID: 1898593
[TBL] [Abstract][Full Text] [Related]
7. Prooxidant action of hinokitiol: hinokitiol-iron dependent generation of reactive oxygen species.
Murakami K; Ohara Y; Haneda M; Tsubouchi R; Yoshino M
Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):392-4. PubMed ID: 16364055
[TBL] [Abstract][Full Text] [Related]
8. Hinokitiol inhibits compound action potentials in the frog sciatic nerve.
Magori N; Fujita T; Kumamoto E
Eur J Pharmacol; 2018 Jan; 819():254-260. PubMed ID: 29225186
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of the hinokitiol-related compounds, gamma-thujaplicin and beta-dolabrin.
Matsumura E; Morita Y; Date T; Tsujibo H; Yasuda M; Okabe T; Ishida N; Inamori Y
Biol Pharm Bull; 2001 Mar; 24(3):299-302. PubMed ID: 11256489
[TBL] [Abstract][Full Text] [Related]
10. Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells.
Tsao YT; Huang YF; Kuo CY; Lin YC; Chiang WC; Wang WK; Hsu CW; Lee CH
Int J Mol Sci; 2016 Feb; 17(2):248. PubMed ID: 26901194
[TBL] [Abstract][Full Text] [Related]
11. Hinokitiol Exerts Anticancer Activity through Downregulation of MMPs 9/2 and Enhancement of Catalase and SOD Enzymes: In Vivo Augmentation of Lung Histoarchitecture.
Huang CH; Jayakumar T; Chang CC; Fong TH; Lu SH; Thomas PA; Choy CS; Sheu JR
Molecules; 2015 Sep; 20(10):17720-34. PubMed ID: 26404213
[TBL] [Abstract][Full Text] [Related]
12. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation.
Huang CH; Lu SH; Chang CC; Thomas PA; Jayakumar T; Sheu JR
Eur J Pharmacol; 2015 Jan; 746():148-57. PubMed ID: 25449038
[TBL] [Abstract][Full Text] [Related]
13. Effects of extracellular matrices on F9 teratocarcinoma stem cells: a crucial role of type IV collagen in the early stage of differentiation of F9 stem cells.
Watanabe K; Toda S; Yonemitsu N; Sugihara H
Pathobiology; 2002-2003; 70(4):219-28. PubMed ID: 12679600
[TBL] [Abstract][Full Text] [Related]
14. Different Cell Responses to Hinokitiol Treatment Result in Senescence or Apoptosis in Human Osteosarcoma Cell Lines.
Yang SC; Chen HY; Chuang WL; Wang HC; Hsieh CP; Huang YF
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163553
[TBL] [Abstract][Full Text] [Related]
15. [Antimicrobial activity of hinokitiol against Legionella pneumophila].
Ishimatsu S; Ohga Y; Ishidao T; Hori H
J UOEH; 2003 Dec; 25(4):435-9. PubMed ID: 14692345
[TBL] [Abstract][Full Text] [Related]
16. In vitro induction of differentiation by ginsenoides in F9 teratocarcinoma cells.
Lee YN; Lee HY; Chung HY; Kim SI; Lee SK; Park BC; Kim KW
Eur J Cancer; 1996 Jul; 32A(8):1420-8. PubMed ID: 8869109
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative Activity of Hinokitiol, a Tropolone Derivative, Is Mediated via the Inductions of p-JNK and p-PLCĪ³1 Signaling in PDGF-BB-Stimulated Vascular Smooth Muscle Cells.
Yang PS; Wang MJ; Jayakumar T; Chou DS; Ko CY; Hsu MJ; Hsieh CY
Molecules; 2015 May; 20(5):8198-212. PubMed ID: 25961161
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNA synthesis causes stem cell differentiation: induction of teratocarcinoma F9 cell differentiation with nucleoside analogues of DNA-synthesis inhibitors and their inducing abilities counterbalanced specifically by normal nucleosides.
Nishimune Y; Kosaka M; Nishina Y; Sumi T; Sakuda M; Takeda M; Matsumoto K
Biochem Biophys Res Commun; 1989 Sep; 163(3):1290-7. PubMed ID: 2528953
[TBL] [Abstract][Full Text] [Related]
19. Production, purification and characterization of the plasminogen activator in teratocarcinoma stem cells induced with sodium butyrate.
Ichikawa N; Miyashita T; Nishimune Y; Matsushiro A
Biken J; 1984 Dec; 27(4):143-51. PubMed ID: 6443174
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of c-jun, but not retinoic acid receptor beta, is associated with F9 teratocarcinoma stem cell differentiation induced by polyamine depletion.
Bjersing JL; Brorsson A; Heby O
J Cell Biochem; 1997 Dec; 67(3):378-85. PubMed ID: 9361192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
